Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference

Sep 02, 2015, 17:54 ET from Array BioPharma Inc.

BOULDER, Colo., Sept. 2, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Healthcare Conference in Boston.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event:

Wells Fargo Securities Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer

Date: 

Thursday, September 10, 2015

Time: 

10:20 a.m. Eastern Time

Webcast:

www.arraybiopharma.com

 

About Array BioPharma 
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

SOURCE Array BioPharma Inc.



RELATED LINKS

http://www.arraybiopharma.com